213013-97-9

Basic information

• Product Name: Benzamide, N-(4-mercaptophenyl)-
• CAS NO: 213013-97-9
• Molecular Formula: C13H11NOS
• Molecular Weight: 229.302
• Mol File: 213013-97-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzamide, N-(4-mercaptophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, N-(4-mercaptophenyl)-(213013-97-9)
• EPA Substance Registry System: Benzamide, N-(4-mercaptophenyl)-(213013-97-9)

Safety Data

• Hazardous Substances Data: 213013-97-9(Hazardous Substances Data)

Upstream product

• 98-88-4 benzoyl chloride 
• 722-27-0 bis(4-aminophenyl)disulfide 
• 1193-02-8 4-aminotiophenol 
• 112308-01-7 S-dimethylcarbamoyl-p-aminothiophenol 
• 91827-26-8 N-benzoyl-S-dimethylcarbamoyl-p-aminothiophenol 
• 16766-10-2 bis-(4-benzoylamino-phenyl)-disulfide 

Downstream Products

• 1258424-23-5 C₂₅H₂₆N₈OS₂ 
• 1258424-24-6 C₂₅H₂₆N₈OS₂ 
• 1258425-82-9 C₂₃H₂₁N₇OS 
• 100865-41-6 benzoic acid-[4-(trans-2-chloro-ethenesulfonyl)-anilide] 
• 100865-32-5 benzoic acid-[4-(trans-2-chloro-vinylmercapto)-anilide] 
• 16766-10-2 bis-(4-benzoylamino-phenyl)-disulfide 
• 100398-35-4 4-benzoylamino-benzenesulfenyl chloride 
• 321586-66-7 2-[[[4-(Benzoylamino)phenyl]sulfanyl]methyl]acrylic acid 

Relevant articles and documents

TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS

Compounds of the formula (I) and formula (II) and pharmaceutically acceptable salts thereof.

QUINOLINE AND QUINOXALINE DERIVATIVES AS INHIBITORS OF KINASE ENZYMATIC ACTIVITY

Compounds of formula (IA) or (IB), are inhibitors of aurora kinase activity: Formula (IA), (IB) wherein -L1Y1-[CH2]z- is a linker radical wherein Y1, L1 and z are as defined in the claims; R6 is C1-C4alkoxy, hydrogen or halo; W represents a bond, -CH2-, -O-, -S-, -S(=O)2-, or -NR5- where R5 is hydrogen or C1-C4 alkyl; Q is =N-, =CH- or =C(X1)- wherein X1 is cyano, cyclopropyl or halo; linker radicals L2 are as defined in the claims; R is a radical of formula (X) or (Y): wherein R1 is a carboxylic acid group (-COOH), or an ester group which is hydrolysable by one or more intracellular carboxylesterase enzymes to a carboxylic acid group; R4 is hydrogen; or optionally substituted C1-C6 alkyl, C3-C7 cycloalkyl, aryl, aryl(C1-C6 alkyl)-, heteroaryl, heteroaryl(C1-C6 alkyl)-, -(C=O)R3, -(C=O)OR3, or -(C=O)NR3 wherein R3 is hydrogen or optionally substituted (C1-C6)alkyl, C3-C7 cycloalkyl, aryl, aryl(C1-C6 alkyl)-, heteroaryl, or heteroaryl(C1-C6 alkyl)-; R41 is hydrogen or optionally substituted C1-C6 alkyl; and D is a monocyclic heterocyclic ring of 5 or 6 ring atoms.

THERMAL REARRANGEMENT OF O-THIOACYL DERIVATIVES OF N-ACYL-N-ARYLHYDROXYLAMINES

The ability of the Ar-N-O-C=S system of atoms to undergo a thermal rearrangement of the Claisen type was investigated.On the basis of the experimental data it was concluded that the process is predominantly nonconcerted in nature.